MLchartDataset catalogue

Palifosfamide

Term · Oncology and biomedicine · MLC-T-ONC-015776

A synthetic mustard compound with potential antineoplastic activity. An active metabolite of ifosfamide covalently linked to the amino acid lysine for stability, palifosfamide irreversibly alkylates and cross-links DNA through GC base pairs, resulting in irreparable 7-atom inter-strand cross-links; inhibition of DNA replication and cell death follow. Unlike ifosfamide, this agent is not metabolized to acrolein or chloroacetaldehyde, metabolites associated with bladder and CNS toxicities. In addition, because palifosfamide does not require activation by aldehyde dehydrogenase, it may overcome the tumor resistance seen with ifosfamide.

Table 1. Record
IdentifierMLC-T-ONC-015776
FieldOncology and biomedicine
AbbreviationIPM-lysine
Synonymsisophosphoramide mustard-lysine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015776",
  "term": "Palifosfamide",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic mustard compound with potential antineoplastic activity. An active metabolite of ifosfamide covalently linked to the amino acid lysine for stability, palifosfamide irreversibly alkylates and cross-links DNA through GC base pairs, resulting in irreparable 7-atom inter-strand cross-links; inhibition of DNA replication and cell death follow. Unlike ifosfamide, this agent is not metabolized to acrolein or chloroacetaldehyde, metabolites associated with bladder and CNS toxicities. In addition, because palifosfamide does not require activation by aldehyde dehydrogenase, it may overcome the tumor resistance seen with ifosfamide.",
  "abbreviation": "IPM-lysine",
  "synonyms": [
    "isophosphoramide mustard-lysine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/palifosfamide/"
}

Record 12,526 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.